Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Diagnostic Imaging × Clear all

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinal Fractures 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Phyllodes Tumor 1 Osteoporosis 1 Nevus 1 Neoplasms 1 Melanoma 1 Liver Cirrhosis 1 Hypertension, Portal 1 Gynecologic Cancer 1 Glioma 1 Fibrosis 1 Dysplastic Nevus Syndrome 1 Disease 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06381531 2025-04-11

TRACE

Tata Memorial Centre

10,000 enrolled

Brain Neoplasms, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡